Ethosuximide API Manufacturer & Supplier in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Ethosuximide API Manufacturer & Supplier in India

Ethosuximide is an anticonvulsant active pharmaceutical ingredient (API) belonging to the succinimide class. It is primarily used for the management of absence seizures (petit mal seizures).

Ethosuximide works mainly by reducing abnormal electrical activity in the brain through inhibition of T-type calcium currents in thalamic neurons, which are important in the generation of absence seizures.

What is Ethosuximide?

Ethosuximide is a synthetic succinimide derivative with anticonvulsant activity. It is particularly selective for absence seizures and is available as an active pharmaceutical ingredient for approved pharmaceutical formulations.

CAS Number: 77-67-8
Molecular Formula: C₇H₁₁NO₂
Molecular Weight: 141.17 g/mol

Mechanism of Action

Ethosuximide primarily inhibits T-type calcium channels in thalamic neurons. This reduces the rhythmic thalamocortical activity associated with absence seizures.

Its pharmacological effects include:

  • Inhibition of T-type calcium currents
  • Reduction of abnormal thalamocortical electrical activity
  • Suppression of absence seizure activity
  • Anticonvulsant effects

Pharmaceutical Applications

Ethosuximide is used in pharmaceutical formulations for:

  • Absence seizures
  • Petit mal epilepsy
  • Childhood absence epilepsy
  • Other clinically appropriate seizure disorders according to approved labeling

Ethosuximide is particularly associated with the treatment of absence seizures rather than generalized tonic-clonic or focal seizures.

Ethosuximide API

Ethosuximide is a succinimide anticonvulsant API with defined chemical and physical characteristics. Pharmaceutical-grade material requires appropriate control of identity, assay, related substances and other quality attributes.

Typical quality evaluation may include:

  • Identification
  • Assay
  • Related substances
  • Water content
  • Residual solvents
  • Elemental impurities
  • Melting point
  • Specific optical rotation, where applicable
  • Particle-size characteristics, where applicable

Quality & Regulatory Considerations

Pharmaceutical-grade Ethosuximide should comply with the applicable pharmacopoeial monograph, approved specification and regulatory requirements.

A qualified supplier should provide Certificate of Analysis (CoA), specification sheet, SDS/MSDS, batch traceability and applicable regulatory documentation.

Storage

Store Ethosuximide in a tightly closed container, protected from excessive moisture, heat and direct light, according to the manufacturer's approved storage and stability requirements.

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 1.0%
Residue on Ignition NMT 0.5%
Heavy Metals NMT 20 ppm
pH (1% Solution) 2.0 – 4.0
Get Bulk Quote via WhatsApp